Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IQV
IQV logo

IQV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy IQVIA Holdings Inc (IQV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
176.590
1 Day change
0.07%
52 Week Range
247.040
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IQVIA Holdings Inc (IQV) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company shows solid financial growth and has positive long-term prospects, the current technical indicators, trading sentiment, and lack of immediate positive catalysts suggest that this is not an optimal entry point. The stock is better suited for monitoring until a clearer bullish trend emerges.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 49.82, suggesting no clear overbought or oversold condition. Moving averages are converging, showing indecision in price direction. The stock is trading near its pivot level of 172.129, with key support at 165.586 and resistance at 178.673. Overall, the technical indicators suggest a neutral trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high Option Volume Put-Call Ratio of 1.66 indicates bearish sentiment in the options market, with significantly more put volume than call volume. Implied volatility is high at 50.31, with an IV percentile of 94, suggesting elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
6

Positive Catalysts

  • The company has shown strong financial performance in the latest quarter, with revenue up 10.26% YoY, net income up 17.62% YoY, and EPS up 23.55% YoY. Analysts have generally maintained positive ratings, with several price targets above the current price, indicating long-term potential.

Neutral/Negative Catalysts

  • Hedge funds and insiders are selling significantly, with hedge fund selling up 581.38% and insider selling up 1004.81%. The stock has a 60% chance of declining 15.85% in the next month based on historical candlestick patterns. Additionally, no recent news or event-driven catalysts support immediate growth.

Financial Performance

In Q4 2025, IQVIA reported strong financial growth with revenue increasing to $4.364 billion (up 10.26% YoY), net income rising to $514 million (up 17.62% YoY), and EPS increasing to 2.99 (up 23.55% YoY). However, gross margin declined to 25.64%, down 5.60% YoY, which could indicate rising costs or pricing pressures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have generally maintained positive ratings, with multiple firms giving Buy or Outperform ratings. Recent price targets range from $174 to $245, with the latest adjustment by Evercore ISI lowering the target to $185 from $225. Analysts see long-term potential but acknowledge risks from AI-related disruptions.

Wall Street analysts forecast IQV stock price to rise
15 Analyst Rating
Wall Street analysts forecast IQV stock price to rise
12 Buy
3 Hold
0 Sell
Strong Buy
Current: 176.460
sliders
Low
215
Averages
258.31
High
290
Current: 176.460
sliders
Low
215
Averages
258.31
High
290
Evercore ISI
Elizabeth Anderson
Outperform
to
Outperform
downgrade
$225 -> $185
AI Analysis
2026-04-08
Reason
Evercore ISI
Elizabeth Anderson
Price Target
$225 -> $185
AI Analysis
2026-04-08
downgrade
Outperform
to
Outperform
Reason
Evercore ISI analyst Elizabeth Anderson lowered the firm's price target on Iqvia to $185 from $225 and keeps an Outperform rating on the shares. The firm made several price target adjustments and additions to the firm's Tactical call lists as part of the firm's healthcare technology and distribution preview for Q1.
TD Cowen
Buy
maintain
$174 -> $213
2026-03-09
Reason
TD Cowen
Price Target
$174 -> $213
2026-03-09
maintain
Buy
Reason
TD Cowen raised the firm's price target on Iqvia to $213 from $174 and keeps a Buy rating on the shares. The firm does not see AI driving revenue headwinds for the company. While AI is likely to reduce drug trial costs by 10%-15%, the savings will be redeployed into additional activity, the analyst tells investors in a research note. TD sees an attractive risk/reward with Iqvia shares down 24% since the start of February.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IQV
Unlock Now

People Also Watch